Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.8%1-day move

₹1123.00

prior close

₹1152.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.1-0.0+0.5+3.8-1.8-6.5-2.0-2.2+1.6+15.8+12.6+5.6+7.3

Up moveDown movePending

AI summary

Tatva Chintan Pharma Chem has informed the BSE and NSE that its trading window will be closed for all designated persons and their immediate relatives starting Wednesday, 01 April 2026. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and full financial year ending 31 March 2026. This is done in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. The communication was signed by Ishwar Nayi, Company Secretary and Compliance Officer, on 24 March 2026.

Likely market impact

This is a routine regulatory filing, not a business event. It signals that the company's Q4 and FY26 audited earnings announcement is approaching, but does not directly affect the stock price. Until results are out, insiders are restricted from buying or selling the company's shares.